slotkoers
Korea S.E.
00:00:00 21-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
14.470
KRW
|
-0,34%
|
|
-3,85%
|
-11,50%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
1.137.466
|
1.009.178
|
1.904.748
|
1.238.276
|
775.668
|
745.892
|
Bedrijfswaarde
1 |
1.658.608
|
1.662.963
|
2.481.633
|
1.885.666
|
1.633.562
|
1.829.947
|
K/w-verhouding
|
61,8
x
|
379
x
|
11,1
x
|
22,6
x
|
23,8
x
|
-13,6
x
|
Dividendrendement
|
1%
|
1,46%
|
1,2%
|
1,47%
|
1,76%
|
1,83%
|
Marktkapitalisatie/omzet
|
0,73
x
|
0,66
x
|
1,11
x
|
0,67
x
|
0,37
x
|
0,36
x
|
Bedrijfswaarde/omzet
|
1,07
x
|
1,09
x
|
1,44
x
|
1,02
x
|
0,79
x
|
0,89
x
|
Bedrijfswaarde/EBITDA
|
17,2
x
|
19
x
|
20,1
x
|
12,7
x
|
11
x
|
25,1
x
|
Bedrijfswaarde/FCF
|
-21,2
x
|
-13,7
x
|
-27,1
x
|
-52,3
x
|
2.448
x
|
-10,2
x
|
FCF Yield
|
-4,71%
|
-7,28%
|
-3,69%
|
-1,91%
|
0,04%
|
-9,84%
|
Price to Book
|
0,01
x
|
1,24
x
|
2,05
x
|
1,21
x
|
0,74
x
|
0,76
x
|
Aantal aandelen (in duizenden)
|
45.402
|
45.402
|
45.402
|
45.402
|
45.402
|
45.402
|
Referentieprijs
2 |
25.100
|
22.250
|
41.500
|
27.150
|
17.000
|
16.350
|
Datum van publicatie
|
19/03/19
|
17/03/20
|
17/03/21
|
21/03/22
|
21/03/23
|
20/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
1.548.715
|
1.524.799
|
1.719.326
|
1.840.559
|
2.079.560
|
2.057.936
|
EBITDA
1 |
96.594
|
87.330
|
123.495
|
148.443
|
148.876
|
73.017
|
Bedrijfsresultaat (EBIT)
1 |
49.312
|
30.388
|
70.664
|
85.999
|
70.221
|
-21.830
|
Operationele Marge
|
3,18%
|
1,99%
|
4,11%
|
4,67%
|
3,38%
|
-1,06%
|
Resultaat voor belastingen (EBT)
1 |
43.189
|
-13.760
|
107.919
|
180.013
|
29.629
|
-81.110
|
Nettowinst (verlies)
1 |
18.467
|
2.957
|
170.960
|
55.270
|
32.823
|
-54.136
|
Nettomarge
|
1,19%
|
0,19%
|
9,94%
|
3%
|
1,58%
|
-2,63%
|
WPA
2 |
406,5
|
58,73
|
3.743
|
1.201
|
715,6
|
-1.203
|
Free Cash Flow
1 |
-78.148
|
-120.998
|
-91.539
|
-36.032
|
667,4
|
-179.994
|
FCF-marge
|
-5,05%
|
-7,94%
|
-5,32%
|
-1,96%
|
0,03%
|
-8,75%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
0,45%
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
2,03%
|
-
|
Dividend per aandeel
2 |
250,0
|
325,0
|
500,0
|
400,0
|
300,0
|
300,0
|
Datum van publicatie
|
19/03/19
|
17/03/20
|
17/03/21
|
21/03/22
|
21/03/23
|
20/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
521.143
|
653.785
|
576.885
|
647.390
|
857.894
|
1.084.055
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
5,395
x
|
7,486
x
|
4,671
x
|
4,361
x
|
5,762
x
|
14,85
x
|
Free Cash Flow
1 |
-78.148
|
-120.998
|
-91.539
|
-36.032
|
667
|
-179.994
|
ROE (netto-inkomsten/eigen vermogen)
|
1,34%
|
-2,06%
|
4,43%
|
7,12%
|
3,04%
|
-3,72%
|
ROA (netto-inkomsten/totale activa)
|
1,19%
|
0,7%
|
1,47%
|
1,6%
|
1,24%
|
-0,37%
|
Totale activa
1 |
1.554.684
|
420.689
|
11.642.626
|
3.464.319
|
2.650.866
|
14.544.950
|
Nettoactief per aandeel
2 |
1.720.377
|
17.903
|
20.248
|
22.473
|
22.857
|
21.591
|
Cashflow per aandeel
2 |
536.409
|
3.887
|
9.858
|
7.354
|
4.595
|
3.844
|
Capex
1 |
117.998
|
138.929
|
108.477
|
116.600
|
73.216
|
89.962
|
Capex/omzet
|
7,62%
|
9,11%
|
6,31%
|
6,34%
|
3,52%
|
4,37%
|
Datum van publicatie
|
19/03/19
|
17/03/20
|
17/03/21
|
21/03/22
|
21/03/23
|
20/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -11,50% | 477 mln. | | +51,63% | 798 mld. | | +41,51% | 633 mld. | | -5,10% | 356 mld. | | +19,90% | 328 mld. | | +9,95% | 304 mld. | | +17,66% | 244 mld. | | +3,39% | 227 mld. | | +10,75% | 216 mld. | | +6,99% | 166 mld. |
Farmaceutische producten - Andere
|